Chun-Fu Chang

Real-world effectiveness of second-line Afatinib versus chemotherapy for the treatment of advanced lung squamous cell carcinoma in immunotherapy-naïve patients

Y. Lai, Shih-Chieh Chang, Chung-Yu Chen, 2021, BMC Cancer.

Factors associated with outcomes of second-line treatment for EGFR-mutant non-small-cell lung cancer patients after progression on first- or second-generation EGFR-tyrosine kinase inhibitor treatment

Y. Lai, Shih-Chieh Chang, Chung-Yu Chen, 2023, Frontiers in Oncology.